Market Overview

Indivior

  • AZN, Biotech, BMY, COLL, DVAX, HRTX

    FDA Decisions In November: The Month In Review

    Friday, December 1, 2017 - 3:05pm

    Rounding out a month marked mostly by positive decisions, FDA announced its approval late for Sublocade, a once-monthly injectable buprenorphine product for the treatment of opioid addiction. U.K.-listed Indivior PLC, the developer of the drug, surged on the London Stock Exchange Friday following...

    Read More...